Investors

ImmuCell Corporation’s (NasdaqCM: ICCC) purpose is to create scientifically-proven and practical products that improve animal health and productivity in the dairy and beef industries. ImmuCell has developed products that provide significant, immediate immunity to newborn dairy and beef livestock. The Company is developing a novel treatment for mastitis, the most significant cause of economic loss to the dairy industry.

Conference Calls

Q2 FY2017 Anticipated Earnings Date – Thursday, August 10, 2017

05-11-17 – First Quarter Fiscal Year 2017 Conference Call

Replay    |    Transcript

02-09-17 – Fourth Quarter & Fiscal Year 2016 Conference Call

Replay    |    Transcript

11-10-16 – Third Quarter Fiscal Year 2016 Conference Call

Replay    |    Transcript

08-11-16 – Second Quarter Fiscal Year 2016 Conference Call

Replay    |    Transcript

05-11-16 – First Quarter Fiscal Year 2016 Conference Call

Replay   |    Transcript

Annual Report

June 14, 2017 – Annual Meeting of Stockholders

2016 Annual Report

Proxy Statement